Jump to content

Harrison Stafford

Legacy Members
  • Posts

    3037
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. Time’s up. You’re good.
  2. The big boys, Google, Amazon, Microsoft, & Meta, will mos def need nuclear to power AI data centers. I think the drop has more to do with a 10% import tariff on Canadian uranium (that’s just a guess).
  3. Gracias. EOSE went from $2.11 in mid- November to $6.33 in mid-January and has begun a slow bleed with a chart that’s concerning. Don’t get greedy, Harrison. Take the “W”. IBRX earnings date is 3/18. Here’s to a nice bump in the sales of Anktiva.
  4. Closed the EOSE position selling all 20,000 shares at $4.96 and made a little under 60k. Both the daily and weekly charts are turning down and tech stocks are getting rained on. If the EOSE slide doesn’t stop at $4.50, $3.50 is the 150 day average and support from last fall’s highs. RGTI becomes interesting at single digits.
  5. The halftime show made me realize I’m not hating to my full potential.
  6. You can hope, but he has a 10 year contract w/Fox for $375 million.
  7. Show Taylor Swift, you cowards.
  8. The KC O-line decided to boycott this game.
  9. So far, this is a Mahomicide.
  10. Who the fuck approved that Coffeemate commercial?
  11. I still hate John Denver
  12. I hate John Denver. That Snoop - Brady commercial didn’t work for me.
  13. I want to see shots of Taylor Swift with every KC three and out.
  14. Generational start from the refs.
  15. Yet another “fortunate” call for the Chiefs. Fuck that shit. I’m cheering for the Eagles. I don’t like it, but fuck the NFL and Roger Goodell.
  16. This shit is awful.
  17. That’s what she said.
  18. Old enough to remember the game being broadcast at the same time on CBS and NBC during Super Bowl I because CBS carried the NFL games and NBC carried the AFL games.
  19. Bragging about high school heroics as an adult is like bragging about T-ball success as a high schooler.
  20. And to think, he was once a bobblehead winner.
  21. That’s a handy excuse.
  22. WHAAAAAAAAAAAAAT??????
  23. ImmunityBio Announces European Medicines Agency Acceptance of Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ JANUARY 27, 2025 -Application covers 30 countries in the European Union -Submission is based on the ongoing QUILT 3.032 study in which 100 patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (NMIBC CIS) have been treated with ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with BCG, achieving a 71% (71/100) complete response (CR) rate -In these responders, the range of duration is 54 months and ongoing, exceeding all duration of response in approved products in this indication
×
×
  • Create New...